Home : Breakthrough Pain : CME/CE Breakthrough Pain Modules

Breakthrough Pain

Objectives

(Worrich) Discuss the effect of local administration of transdermal fentanyl on peripheral opioid analgesia in patients with chronic pain.
(Bercovitch) Discuss factors which may contribute to the level of opioid dose requirement in terminal cancer patients.
(Blick) Describe the unique delivery system presented by the fentanyl buccal tablet.
(Driver) List the characteristics of breakthrough pain that should be evaluated to provide a working diagnosis.
(Freye) State the current recommendations for the effective dose of breakthrough pain medication as a percentage of the total daily opioid dose.
(Hagen) State the importance of identification of predictive factors to the management of breakthrough cancer-related pain.
(McCarberg) Outline strategies for treating patients with breakthrough pain.
(Mercadante) Evaluate the safety and effectiveness of intravenous morphine for breakthrough pain in advanced cancer patients receiving transdermal buprenorphine.
(Payne) Review major clinical issues related to recognition and diagnosis of breakthrough pain.
(Vasudevan) Discuss the addition of intrathecal morphine to a combined spinal-epidural technique for breakthrough labor pain.

Professional Login

Email Address

Password

» Retrieve Your Password

» Create A New Account

Twitter Updates

Don't miss the 2009 Dannemiller Anesthesia Review Course. Visit the Website to Learn More, or call (800) 328-2308.